Download file (1.21MB)
Download as zip (1.18MB)

コレクション

引用

説明:

Use of solubilization carriers for poorly soluble drugs may disturb transmembrane absorption by lowering the activity of drug molecules, which is known as the solubility-permeability interplay. However, although many in vitro studies have indicated the negative impacts of use of solubilization carriers for oral absorption, in vivo studies that showed the interplay effect are limited. This study provides systematic in vitro, in situ, and in vivo investigation of the interplay effect of cyclodextrin using dexamethasone as a model drug. The evaluation methods included permeation through polymeric, artificial lipid, cell, and intestinal closed-loop membranes. Then, the results were compared with oral administration studies in mice and dogs. Although the interplay effect was clearly observed in the in vitro studies, no obvious interplay was found in the in vivo studies, suggesting that the interplay effect is more prominent in the in vitro permeation studies. Absence of in vivo interplay was attributed to the dilution effect in the gastrointestinal tract, interaction of the drug with living components, and clearance of the drug after membrane permeation. Overall, this investigation clearly demonstrated the applicability and limitations of in vitro permeation studies for predicting the interplay effects of solubilizers after the oral administration.

権利情報:

• Creative Commons BY-NC-ND Attribution-NonCommercial-NoDerivs 4.0 International
  

キーワード: Solubility-permeability interplay, Solubilization, Poorly soluble drug, Oral absorption, Cyclodextrin

刊行年月日: 2024-10-22

出版者: Elsevier BV

掲載誌:

• Journal of Pharmaceutical Sciences (ISSN: 00223549) vol. 114 issue. 1 p. 361-370

研究助成金:

原稿種別: 著者最終稿 (Accepted manuscript)

MDR DOI: https://doi.org/10.48505/nims.5523

公開URL: https://doi.org/10.1016/j.xphs.2024.10.008

関連資料:

その他の識別子:

連絡先:

更新時刻: 2025-10-23 08:30:07 +0900

MDRでの公開時刻: 2025-10-23 08:18:16 +0900